ArticleInternational journal of radiation oncology, biology, physics2015

Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion.

Matthew J Nyflot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.